http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-93378-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21cfb7dd79973529725cde19b4f43cba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2006-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80aa29ef7932efe9071039f38eade720
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd507f02e356aa650a4e4be41bc000a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eb9f9cf7552b425817d850c5d7d65fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacd5371acafbc49185773e5ed96a11d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9237dd48fdf618a536854eb28caea142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3090990291942fa680f4b0744c6cf0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25339a1f323cd5adb820845f5121072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12e2b997c9b4dd15ea0a421633961161
publicationDate 2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-93378-C2
titleOfInvention 3-AMINOCARBASOLIC COMPOUND, PHARMACEUTICAL COMPOSITION THAT EE CONTAINS, AND METHOD FOR EE PRODUCTION
abstract A compound of the formula (I), (I) in which R1, R2, R3, R4, R5, R6, X and Y have the values specified in the description, and its pharmaceutically acceptable salts. A pharmaceutical composition that contains a compound of the formula (I) or its pharmaceutically acceptable salt. The method of obtaining the above-mentioned compound of formula (I) and their pharmaceutically acceptable salts. Compound of formula (I), (I) in which R1, R2, R3, R4, R5, R6, X and Y have the meanings indicated in the description, and its pharmaceutically acceptable salts. A pharmaceutical composition containing a compound of formula (I) or its pharmaceutically acceptable salt. A method of obtaining the above-mentioned compound of formula (I) and its pharmaceutically acceptable salts.
priorityDate 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725974

Total number of triples: 29.